EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma

Siyu Xia, Lihua Chen, Min Yu, Jiana Li, Jiaxin Chen, Fei Xu, Mengdong Ni, Chaohua Liu, Xiaohua Wu iD, Xiaojun Chen, Jiajia Li iD

Journal for ImmunoTherapy of Cancer · 2024-11 · 12 (11) · e010069

DOI: 10.1136/jitc-2024-010069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 27.11.2024. Verfasst von Siyu Xia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian clear cell carcinoma (OCCC) is a rare and chemo-resistant subtype of ovarian cancer. While immunotherapy has demonstrated effectiveness in some OCCC cases, the mechanisms for heterogeneous immunoreactivity and potential combinatory strategies remain unclear.

Methods

Tumor samples from 13 patients with OCCC underwent single-cell mRNA-seq and TCR-seq to generate 1 40 683 cells transcriptome, while additionally 31 formalin-fixed paraffin-embedded samples were used for immunohistochemistry. Spatial transcriptomics of two OCCC samples and bulk RNA-seq of 58 patients were incorporated for spatial and interpatient level explorations. Serum tumor markers and radiologic images of three patients with OCCC who received combinatory VEGF and PD-1 inhibition were retrospectively analyzed.

Results

OCCC exhibited a dynamic immune architecture shaped by genetic and therapeutic pressure. ARID1A mutation linked to baseline immune activation, correlated with an enrichment of neoantigen-reactive CXCL13 + CTLA4 + CD8 + T cells (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsHumansFemaleAdenocarcinoma, Clear CellTumor MicroenvironmentMiddle AgedRetrospective StudiesAged

Stichwörter der Autor:innen

combination therapyescape/evasionimmunotherapyovarian cancertumor microenvironment - TME

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China.
  • Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China jiajiali_shca@126.com doccxj2020@163.com wu.xh@fudan.edu.cn.

ORCID-Profile: Xiaohua Wu, Jiajia Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xia, S., Chen, L., Yu, M., Li, J., Chen, J., Xu, F., Ni, M., Liu, C., Wu, X., Chen, X., & Li, J. (2024). Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma. Journal for ImmunoTherapy of Cancer, 12(11), e010069. https://doi.org/10.1136/jitc-2024-010069

Vancouver

Xia S, Chen L, Yu M, Li J, Chen J, Xu F, et al. Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma. Journal for ImmunoTherapy of Cancer. 2024;12(11):e010069. doi:10.1136/jitc-2024-010069

BibTeX
@article{Xia2024,
  author = {Xia, Siyu and Chen, Lihua and Yu, Min and Li, Jiana and Chen, Jiaxin and Xu, Fei and Ni, Mengdong and Liu, Chaohua and Wu, Xiaohua and Chen, Xiaojun and Li, Jiajia},
  title = {Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {11},
  pages = {e010069},
  doi = {10.1136/jitc-2024-010069}
}
Kostenlos starten →